期刊文献+

CD40/CD40L系统与动脉粥样硬化 被引量:2

CD40/CD40L system and atherosclerosis
原文传递
导出
摘要 动脉粥样硬化是一种慢性炎症性疾病.动脉粥样硬化斑块破裂和血栓形成可导致急性心脑血管事件.炎性介质CD40/CD40L广泛存在于与动脉粥样硬化相关的细胞,参与斑块内炎症反应,释放促炎细胞因子,降解细胞外基质,提高促凝活性,促进动脉粥样硬化的进展和斑块易损性.干预CD40/CD40L信号系统可能成为减缓动脉粥样硬化进展和稳定动脉粥样硬化斑块的一种有效治疗策略. Atherosclerosis is a chronic inflammatory disease.Atherosclerotic plaque rupture and thrombosis may result in cardio-cerebrovascular events.Inflammatory mediator CD40L widely exists in cells associated with atherosclerosis.They participate in plaque inflammatory response,release proinflammatory cytokines,degrade extracellular matrix,improve procoagulant activity,and promote the progression of atherosclerosis and plaque vulnerability.Intervening CD40/CD40L signaling system may become an effective treatment strategy to slow the progress of atherosclerosis and stabilize atherosclerotic plaques.
出处 《国际脑血管病杂志》 北大核心 2013年第12期947-952,共6页 International Journal of Cerebrovascular Diseases
关键词 抗原 CD40 CD40配体 动脉粥样硬化 炎症 Antigens CD40 CD40 Ligand Atherosclerosis Inflammation
  • 相关文献

参考文献60

  • 1Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev lmmunol, 2006, 6: 508-519.
  • 2Chamorro A. Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis, 2004, 17(Suppl 3): 1-5.
  • 3Kiechl S, Werner P, Knoflach M, et al. Subclinical atherosclerosis, markers of inflammation, and oxidative stress//Nicolaides A, Beach KW, Kyriacou E, et al. Ultrasound and Carotid Bifurcation Atherosclerosis. London: Springer-Verlag London Limited, 2012:487- 509.
  • 4Hakkinen T, Karkola K, Yla-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch, 2000, 437: 396-405.
  • 5Inwald DP, McDowall A, Peters MJ, et al. CIM0 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Ch'c Res, 2003, 92: 1041-1048.
  • 6Math F, Schonbeck U, Sukhova GK, et al. Reduction of atherosclerosis in mice by inhNition of CD40 signalling. Nature, 1998, 394: 200-203.
  • 7Lutgens E, Gorelik L, Daemen MJ, et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med, 1999, 5: 1313- 1316.
  • 8Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 1998, 391 : 591-594.
  • 9Lutgens E, Daemen MJ. CIMO-CIMOL interactions in atherosclerosis. Trends Cardiovasc Med, 2002, 12: 27-32.
  • 10Schanbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci, 2001, 58: 4-43.

同被引文献10

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部